New York city, United States (February 16, 2010)
No company, surgeon or industry analyst can afford to miss this meeting. With more than 50 presentations by the stem cell therapy commercial and technology leaders, this is the most critical stem cell meeting of the year. Featuring:
• 6 major new stem cell therapies, all forecast to reach physicians and surgeon practitioners in 2010• New allograft products, new forms of autologous stem cell technologies, and at least one FDA approved stem cell drug• Major new studies showing rehydration of the disc nucleus, new heart muscle regeneration studies, and others• 35 corporate presenters• 300 attendees expected• Unparalleled networking opportunities• Presentations will include the description of a dramatic new source of stem cells―placental tissues• Scientific panels, individual tracks for stem cells tools & instruments, and your personal copy of the annual Stem Cell Market Analysis & Forecast (2009-2019) containing profiles of the world’s top 50 stem cell companies• And, of course, Robin Young’s updated 10-year forecast for the industry
"The role of RNA chaperone Hfq in RNA translations"
Prague, Czech Republic, March 29, 2010
BIOFORUM 2010
Lodz, Poland, May 19-21, 2010
Mendel lectures: How DNA recombination maintains genome integrity
Mendel museum, Brno, April 15, 2010
microRNA in Human Disease & Development
Cambridge, United States, March 22-24, 2010
Pharma Pricing & Market Access Outlook 2010
London, England, March 23-26, 2010
Synthetic Biology in Pharma
Cambridge, United States, March 30-31, 2010
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
© 2006 South Moravian Innovation Centre
Interesting biotechnology content:
Biotechnology Events - Current biotechnology events
DNA - Deoxyribonucleic acid (DNA) at Wikipedia
Why cancer cells just won’t die
Engineered pea seeds protect against parasites